Skip to main content

Table 3 General population utility values

From: Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada

  Utility Values
Age Females Males
35-44 0.91 0.91
45-54 0.85 0.84
55-64 0.81 0.78
65-74 0.78 0.78
75+ 0.71 0.75